Apply for RFA FD 21 019
- The Department of Health and Human Services, Food and Drug Administration in the consumer protection, food and nutrition, science and technology and other research and development sector is offering a public funding opportunity titled "Dermal Physiologically-based Pharmacokinetic (PBPK) Models Accounting for the Absorption and Evaporation of Vehicle/Co-solvent following the Application of Generic Dermatological Products (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.103.
- This funding opportunity was created on Feb 17, 2021.
- Applicants must submit their applications by Apr 22, 2021.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
Browse more opportunities from the same category: Consumer Protection, Food and Nutrition, Science and Technology and other Research and Development
Next opportunity: American Lobster Research Program
Previous opportunity: RINDRA program
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.Apply for RFA FD 21 019
Applicants also applied for:
Applicants who have applied for this opportunity (RFA FD 21 019) also looked into and applied for these:
|Funding Number||Funding Title|
|PAR 21 178||Drug Development Tools Research Grants (U01) Clinical Trial Optional|
|RFA FD 21 020||Impulse Oscillometry Endpoint Sensitivity to Regional Lung Function Changes using Computational Fluid Dynamics (CFD) (U01) Clinical Trial Required|
|RFA FD 21 022||Expanding the opioids system modeling efforts to more comprehensively address fentanyl, stimulants use, polysubstance use and associated outcomes.(U01) Clinical Trials Not Allowed|
|RFA FD 21 026||Analgesic, Anesthetic and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) (U01) Clinical Trials Not Allowed|
|RFA FD 21 025||SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership (PPP) under PASI (Pediatric Anesthesia Safety Initiative) (U01) Clinical Trials Not Allowed|
|RFA FD 21 035||Pediatric and Perinatal COVID-19 Registry (U18) Clinical Trials Optional|
|RFA FD 22 003||Innovation Award: COVID-19 and Health Equity (U01) Clinical Trials Optional|
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!Apply for Grants
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA FD 21 019", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.